1. Home
  2. ICCC vs LTRN Comparison

ICCC vs LTRN Comparison

Compare ICCC & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

SELL

Current Price

$6.55

Market Cap

55.5M

Sector

Health Care

ML Signal

SELL

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.36

Market Cap

49.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
LTRN
Founded
1982
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.5M
49.9M
IPO Year
1987
2020

Fundamental Metrics

Financial Performance
Metric
ICCC
LTRN
Price
$6.55
$3.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
39.6K
56.8K
Earning Date
02-25-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
N/A
Revenue
$27,769,304.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$25.45
N/A
Revenue Growth
16.49
N/A
52 Week Low
$4.28
$2.55
52 Week High
$7.60
$6.12

Technical Indicators

Market Signals
Indicator
ICCC
LTRN
Relative Strength Index (RSI) 63.60 48.25
Support Level $5.80 $2.90
Resistance Level $7.12 $3.56
Average True Range (ATR) 0.39 0.25
MACD 0.04 0.01
Stochastic Oscillator 64.10 55.91

Price Performance

Historical Comparison
ICCC
LTRN

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: